GLOW Mezcla (GHK-Cu| TB 500|BPC 157) 70mg

Buy GLOW Blend (GHK-Cu+BPC157+TB500) Research Peptide Online

GLOW Blend represents a multi-component peptide research formulation combining three distinct bioactive compounds: GHK-Cu (copper-chelated tripeptide), BPC157 (15-amino-acid synthetic peptide), and TB500 (beta-4 thymosin). This three-peptide combination enables investigation of synergistic and independent mechanisms across overlapping biological pathways related to tissue integrity, remodeling, and cellular resilience.

GHK-Cu functions as a copper-coordinated complex that interacts with collagen synthesis, matrix metalloproteinase regulation, and growth factor signaling cascades. Research demonstrates effects on fibroblast proliferation and extracellular matrix deposition in dermal and subcutaneous tissues. BPC157 exhibits diverse biological activity including modulation of nitric oxide synthesis, growth hormone secretion signaling, and vascular endothelial function. TB500 (beta-4 thymosin) represents an actin-regulating peptide involved in cytoskeletal dynamics and cellular migration processes.

Combining these three components allows researchers to examine whether simultaneous targeting of collagen homeostasis (GHK-Cu), vascular signaling (BPC157), and cellular motility (TB500) produces additive or synergistic effects on tissue repair processes in preclinical models. Published literature on individual components (Pickart et al., 1980; Sikiric et al., 2019; Goldstein et al., 2005) provides mechanistic foundation; however, comparative multi-component protocols remain limited, making this blend valuable for exploratory research design.

GLOW Blend (GHK-Cu+BPC157+TB500) Product Specifications:

– Form: Lyophilized blend – Composition: GHK-Cu (5mg), BPC157 (2.5mg), TB500 (2.5mg) per vial – Total quantity: 10mg – Reconstitution: Bacteriostatic water or saline solution (2–4mL per protocol) – Storage: 2–8°C; moisture-protected container essential – Purity: ≥95% (HPLC-verified for each component) – Stability: 72 hours post-reconstitution at 4°C

Research Use Only.

This formulation is intended exclusively for in vitro and preclinical research applications. Not approved for human use, therapeutic investigation, or systemic administration outside regulated research facilities.